Zobrazeno 1 - 10
of 31
pro vyhledávání: '"V I, Shevelev"'
Autor:
V. I. Shevelev, S. G. Kanorskyi
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 12, Iss 4, Pp 10-15 (2013)
Aim. To compare the effects of various antihypertensive therapy (AHT) variants on the ultrasound-assessed elasticity of common carotid arteries (CCA) and thoracic aorta in elderly patients with nonvalvular atrial fibrillation (AF).Material and method
Externí odkaz:
https://doaj.org/article/67c5cca0c403466ba3ab1e22da5cb33f
Autor:
V. I. Shevelev, S. G. Kanorskyi
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 12, Iss 1, Pp 46-53 (2013)
Aim. To compare effectiveness and safety of warfarin, dabigatran, and clopidogrel therapy as thromboembolism (TE) prevention strategy across the age groups in patients with nonvalvular atrial fibrillation (AF).Material and methods. The study included
Externí odkaz:
https://doaj.org/article/cd4f2a0ce0984bc8909fe43298b2fb62
Autor:
S G Kanorsky, V I Shevelev
Publikováno v:
Scopus-Elsevier
We compared efficacy and safety of warfarin with those of direct thrombin inhibitor dabigatran, factor Xa inhibitors rivaroxaban and apixaban used for stroke prevention in 280 patients aged 65-80 years with non-valvular atrial fibrillation. Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c212254e34a32e8e8ac2231348bcedc7
https://doi.org/10.18565/cardio.2015.10.58-63
https://doi.org/10.18565/cardio.2015.10.58-63
Autor:
V I, Shevelev, S G, Kanorsky
Publikováno v:
Klinicheskaia meditsina. 93(7)
This study was designed to compare effectiveness and safety of warfarin, direct thrombin inhibitor dabigatran, Xa factor inhibitors rivaroxaban and apixaban used to prevent stroke in 280 elderly patients in patients with age-specific non-valvular atr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::902ffc8f7bbe3f48cbc22a7a2a63aa28
https://pubmed.ncbi.nlm.nih.gov/26596056
https://pubmed.ncbi.nlm.nih.gov/26596056
Autor:
V I, Shevelev, S G, Kanorsky
Publikováno v:
Klinicheskaia meditsina. 90(10)
We compared the efficacy and safety of warfarin, dabigartan, and clopidogrel used to prevent tromboembolism in 210 elderly patients with non-valvular atrial fibrillation depending on the age. In patients aged 65--74 yr treatment with dabigartan (110
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1463b1fd44ae853d92306fd9c0567a5b
https://pubmed.ncbi.nlm.nih.gov/23285766
https://pubmed.ncbi.nlm.nih.gov/23285766
Autor:
V I, Shevelev, S G, Kanorskiĭ
Publikováno v:
Klinicheskaia meditsina. 90(9)
This comparative ultrasound study included 210 patients aged 65-80 years with non-valvular atrial fibrillation treated with the use of 4 different therapeutic modalities. Intake of perindopril, valsartan, valsartan + rozuvastatin, and lercanidipine r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a56c2c66647cdc705e67fdf6bb26a292
https://pubmed.ncbi.nlm.nih.gov/23214018
https://pubmed.ncbi.nlm.nih.gov/23214018
Autor:
V I, Shevelev, S G, Kanorskiĭ
Publikováno v:
Kardiologiia. 52(8)
Basing on the data of ultrasound study we compared effects of various antihypertensive therapies on elastic properties of common carotid arteries and the thoracic aorta in 133 patients aged 65-80 years with nonvalvular atrial fibrillation (AF). The u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6eaa707caa34c30354e71d4e4d7030ce
https://pubmed.ncbi.nlm.nih.gov/23098396
https://pubmed.ncbi.nlm.nih.gov/23098396
Autor:
V I, Shevelev, S G, Kanorskiĭ
Publikováno v:
Kardiologiia. 52(7)
We compared efficacy and safety of warfarin, direct thrombin inhibitor dabigatran and clopidogrel in prevention of stroke in 210 patients with nonvalvular atrial fibrillation (AF) aged 65-80 years. The use of dabigatran (110 mg twice daily) for 12 mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba5bea38644c8f2ba6f969e3c617cf58
https://pubmed.ncbi.nlm.nih.gov/22839715
https://pubmed.ncbi.nlm.nih.gov/22839715
Autor:
A E, Ditiatkov, O Iu, Antonova, V I, Shevelev, A V, Rvacheva, E I, Kaznacheeva, V B, Beĭlina, G A, Tkachev, K A, Zykov
Publikováno v:
Problemy tuberkuleza i boleznei legkikh. (3)
To study the immunological features in chronic bronchitis (CB) patients with great residual changes (GRC) after prior pulmonary tuberculosis, the authors examined two groups: 1) 40 CB patients with GRC after prior pulmonary tuberculosis (a study grou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9133e15baea493f211fb29f2df346f6d
https://pubmed.ncbi.nlm.nih.gov/18453053
https://pubmed.ncbi.nlm.nih.gov/18453053
Publikováno v:
Kardiologiia. 47(1)
Patients (n=263, age 49-64 years) with persistent nonvalvular atrial fibrillation were subjected to controlled treatment aimed at restoration and maintenance of sinus rhythm (n=134) or slowing of rate of ventricular contractions. Efficacy of compleme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::47a4cabf312ffc76f62a2f1eb3435629
https://pubmed.ncbi.nlm.nih.gov/17426677
https://pubmed.ncbi.nlm.nih.gov/17426677